ConductScience.org, home

Paper41222708

Pharmacogenetics in advanced Parkinson's disease.

Kulisevsky J and 10 others. J Neural Transm (Vienna), 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Pharmacogenetics in advanced Parkinson's disease. Papers, record 41222708. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41222708

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacogenetics in advanced Parkinson's disease.
PubMed
Journal
J Neural Transm (Vienna)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-11-05
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kulisevsky JJaimehttps://orcid.org/0000-0003-4870-1431
2García-Ruíz PPedro
3Outeiro TFTiago Fleming
4Gurevich TTanya
5Klivènyi PPéter
6Van Laar TTeus
7Milanov IIvan
8Pirker WWalter
9Popescu BOBogdan O
10Toft MMathias
11Szász JAJózsef Attila

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Parkinson DiseaseMajor topic
PharmacogeneticsMajor topic
Antiparkinson AgentsMajor topic
Humans

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140542221Implementing health economics for pharmacogenomics research translation in Africa.Commun Med (Lond)2025https://conductscience.org/library/papers/40542221PubMed
230640364Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease.JAMA Neurol2019https://conductscience.org/library/papers/30640364PubMed
330357892Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts.Ann Neurol2018https://conductscience.org/library/papers/30357892PubMed
435517045Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson's Disease and Dopaminergic Treatment Adverse Events.Front Aging Neurosci2022https://conductscience.org/library/papers/35517045PubMed
539812497New Multiomic Studies Shed Light on Cellular Diversity and Neuronal Susceptibility in Parkinson's Disease.Mov Disord2025https://conductscience.org/library/papers/39812497PubMed
612011284MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD.Neurology2002https://conductscience.org/library/papers/12011284PubMed
738243775Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach.Mov Disord2024https://conductscience.org/library/papers/38243775PubMed
837025429Association of Catechol-O-Methyltransferase Gene Polymorphisms and Haplotypes in the Levodopa-Induced Adverse Events in Subjects with Parkinson's Disease.Indian J Clin Biochem2023https://conductscience.org/library/papers/37025429PubMed
932355309Genome-wide association study identifies zonisamide responsive gene in Parkinson's disease patients.J Hum Genet2020https://conductscience.org/library/papers/32355309PubMed
1039551668Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease - What is missing? A systematic review.Parkinsonism Relat Disord2025https://conductscience.org/library/papers/39551668PubMed
1122139623What factors influence motor complications in Parkinson disease?: a 10-year prospective study.Clin Neuropharmacol2012https://conductscience.org/library/papers/22139623PubMed
1236582064Pharmacogenomics-a New Frontier for Individualized Treatment of Parkinson's Disease.Curr Neuropharmacol2023https://conductscience.org/library/papers/36582064PubMed
1329746402Update in therapeutic strategies for Parkinson's disease.Curr Opin Neurol2018https://conductscience.org/library/papers/29746402PubMed
1436342310Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert.Rev Neurol2022https://conductscience.org/library/papers/36342310PubMed
1530363349Pharmacogenetics of Parkinson's Disease in Clinical Practice.Mov Disord Clin Pract2017https://conductscience.org/library/papers/30363349PubMed
1610636440Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?Clin Genet1999https://conductscience.org/library/papers/10636440PubMed
1733848468Parkinson's disease.Lancet2021https://conductscience.org/library/papers/33848468PubMed
1825645960Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.Synapse2015https://conductscience.org/library/papers/25645960PubMed
1919759203A clinico-pathological study of subtypes in Parkinson's disease.Brain2009https://conductscience.org/library/papers/19759203PubMed
2012119748The impact of pharmacogenetics and pharmacogenomics on drug discovery.Nat Rev Drug Discov2002https://conductscience.org/library/papers/12119748PubMed

See all 48 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42796091Long-Term Clinical Efficacy, Safety, and Polypharmacy Simplification of Levodopa-Entacapone-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: An 18-Month Longitudinal Study.J Clin Med2026https://conductscience.org/library/papers/42796091PubMed
42198211Clinical Outcomes and Predictors of Response to Levodopa-Entacapone-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: A Retrospective Cohort Study over a 4-Year Period.Pharmaceutics2026https://conductscience.org/library/papers/42198211PubMed
42022561Psychiatric pharmacogenomics: from genetic evidence to clinical integration - structural, educational, and ethical challenges.Front Pharmacol2026https://conductscience.org/library/papers/42022561PubMed
40906256Revisiting Parkinson's disease definition and classification: insights from two emerging biological frameworks.J Neural Transm (Vienna)2025https://conductscience.org/library/papers/40906256PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41222708

GET https://conductscience.org/api/papers/v1/41222708/references?page=2